NEWS
UB-311 Vaccine Safe, Effective in Mild Alzheimer’s Patients, Phase 2a Trial Suggests
| Alzheimer's News Today

United Neuroscience’s Alzheimer’s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according to Phase 2a trial results.

FSD Pharma aims to have the world’s largest hydroponic indoor cannabis production and processing facility
| Proactive Investors

“HUGE” is the Canadian stock ticker for FSD Pharma Inc (CSE:HUGE) (OTCQB: FSDDF) (FRA:0K9) and it hints at the size of the company’s aspirations. Its aim? The development of high-quality, indoor-grown, pharmaceutical-grade cannabis. But it’s even more than that. The company intends to target all legal aspects of the cannabis industry: cultivation, processing, manufacturing, extracts […]

Despite market uncertainty, healthcare CEOs of all stripes remain upbeat about 2019
| MedCity News

The market gyrations and the shutdown. The trade wars and global uncertainty. None of the above has squashed the sunny optimism that a group of healthcare CEOs demonstrated at a roundtable discussion during the annual J.P. Morgan Healthcare Conference in San Francisco last week.